Glenmark Life Sciences Files IPO Papers With Sebi

Popular

RBI asks HDFC Bank to stop digital launches and credit card...

The Reserve Bank of India (RBI) has asked the country's largest private sector lender, HDFC bank to stop all launches of its digital business...

Assam’s Dibrugarh University Teacher Arrested For Sharing Porn Video: Police

During interrogation, the accused confessed to the crime. (Representational)Dibrugarh: An assistant professor in Assam's Dibrugarh University was arrested today for allegedly uploading pornographic content...

Process to avail full refund on Lockdown Air Tickets

The Supreme Court approved the Directorate General of Civil Aviation's (DGCA) proposal on air tickets refund and credit shell on flights booked prior and...

Why was CDS Gen. Bipin Rawat’s attending China-owned MG Motor event;...

US Ambassador Kenneth Juster greets CDS Gen Bipin Rawat with elbow bump | Watch ...

Explained: How new H-1B visa regime will impact Indians, Indian firms

In yet another policy stance change on H-1B visa within six months, the US administration on October 6 said it was announcing an “interim...

Glenmark Life Sciences is the wholly-owned arm of Glenmark Pharmaceuticals

Glenmark Pharmaceuticals said on Saturday that its wholly-owned arm Glenmark Life Sciences has filed preliminary papers with the market regulator Sebi for an initial public offer. The offer will comprise a fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals, Glenmark Pharma said.

“Glenmark Life Sciences Limited, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited, has today, i.e. on April 16, 2021, filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer,” Glenmark Pharma said in a regulatory filing to the stock exchanges. The IPO will be subject to market conditions.

The IPO proceeds will be used to fund capital expenditure requirements and for general corporate purposes.

Kotak Mahindra Capital, BofA Securities, Goldman Sachs, DAM Capital, SBI Capital and BoB Capital are the investment bankers for the IPO.

On Friday, the shares of Glenmark Pharma ended the session at Rs 571.90, higher by 6.54 per cent, on the BSE.

Source link

Latest News

Your Queries – Income Tax: Give scrip-wise details in ITR to calculate long term...

The resultant capital gain shall be brought to tax accordingly.By Chirag Nangia I had purchased shares of one firm in 2016 and again in 2018....

Home Loans: Now is the time to renegotiate your loan terms

When repriced @6.75%, the EMI is Rs 88,491. A monthly saving of Rs 10,000.By Raj KhoslaAs the second wave of pandemic hits India, it’s...

Canara Bank posts ₹1,010 cr. Q4 net profit

Canara Bank reported fourth quarter net profit of ₹1,010 crore as against a net loss of ₹6,567 crore in the corresponding year-earlier period. The...

Maruti Suzuki, Zydus Hospital partner to open new hospital in Gujarat

Maruti Suzuki India in partnership with Zydus Hospitals has announced the start of a multi-speciality hospital at Sitapur in Ahmedabad, Gujarat. Built at...

Google rolls out News Showcase in India

Google on Tuesday announced the roll-out of News Showcase in India with 30 news publishers, including national, regional and local news organisations.The News Showcase...